Three novel biomarkers (SCG2, ASPN, and GEM) were screened, and the findings are displayed in Figure 5A. The genes (EGR1, SLIT2, and FOS) were rejected because they were previously correlated with the development of endometriosis in the literature. This evidence concerns the gene EGR1 and endometriosis.